Market News AIOpen the app

LAB stock news · Standard BioTools Inc.

Stories about Standard BioTools Inc. (LAB) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for LAB

Follow Standard BioTools Inc. (LAB) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LAB
Free on the App Store and Google Play, or on the web.
  1. Nov 16, 2026, 4:34 PM ET · Deal

    Standard BioTools Inc. shared news about a lawsuit connected to its merger with Treeline Biosciences.

    Bad for LAB

    Standard BioTools received 15 demand letters and faced 2 lawsuits over its merger voting papers. The legal challenges add uncertainty, making this negative for the company.

  2. Oct 5, 2026, 4:28 PM ET · Market

    Standard BioTools Inc. says it will sell its Microfluidics business to ARCHIMED soon.

    Neutral

    Standard BioTools agreed to sell its Microfluidics business, but gave no sale price or expected gains. The deal still needs to close, so the announcement does not change the company's outlook.

  3. Sep 30, 2026, 5:31 PM ET · Market

    Standard BioTools Inc. has signed a new deal with Element Biosystems after ending its old agreement with Multiplex Bio.

    Neutral

    LAB agreed to sell its mass cytometry business for $5.5 million, but it also agreed to pay a fee and still needs approvals. The story does not clearly change its outlook.